Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00631943Phase 3Completed
Phase 3, open-label, single-arm trial of pregabalin in Peripheral neuropathic pain, sponsored by Viatris. Primary endpoints: Short Form McGill Pain Questionnaire Visual Analog Score and Weekly mean pain score. Started Nov 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00631943.